GRO

GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer

Retrieved on: 
Lundi, mars 18, 2024

Dr. Lodie most recently worked as Chief Scientific Officer at Quell Therapeutics where she led the company’s scientific strategy and worked to build their immune-driven pipeline.

Key Points: 
  • Dr. Lodie most recently worked as Chief Scientific Officer at Quell Therapeutics where she led the company’s scientific strategy and worked to build their immune-driven pipeline.
  • “We are delighted to add Tracey to our executive team.
  • Her world-class experience in immunology, clinical translation, development, and commercialization will be instrumental as we advance our programs into the clinic,” said Daniel J. Mandell, PhD, Chief Executive Officer of GRO Biosciences.
  • Dr. Lodie’s addition to the executive team brings critical management expertise to support the continued evolution of GRO Biosciences into a clinical-stage organization.”

Spring Capital Successfully Exits Investment in Catenda, a Leader in Construction Project Software

Retrieved on: 
Vendredi, mars 15, 2024

As the lead investor, Spring Capital has sold all its shares in the transaction on a high IRR for itself and co-investors.

Key Points: 
  • As the lead investor, Spring Capital has sold all its shares in the transaction on a high IRR for itself and co-investors.
  • Founded in 2009 as a spin-off from SINTEF, Catenda is a leader in Building Information Management (BIM) & Common Data Environment (CDE) software.
  • Since Spring Capital’s investment through its Scandinavian investment entity Polaris, Catenda has grown significantly, becoming a trusted partner for construction companies and municipalities seeking innovative solutions for large-scale projects.
  • Construction companies across Europe and Japan have widely adopted the company's software, seeking to streamline operations and improve project outcomes.

Pearl Bio Inks Collaboration with Merck to Discover Novel Engineered Biologics

Retrieved on: 
Mardi, mars 12, 2024

Pearl Bio (a synthetic biology company backed by Khosla Ventures) today announced that it has entered a license, collaboration and option agreement with Merck, known as MSD outside of the United States and Canada, to discover biologic therapies comprising non-standard amino acids.

Key Points: 
  • Pearl Bio (a synthetic biology company backed by Khosla Ventures) today announced that it has entered a license, collaboration and option agreement with Merck, known as MSD outside of the United States and Canada, to discover biologic therapies comprising non-standard amino acids.
  • "Merck is excited to collaborate with Pearl, a pioneer in developing recoded organisms, to produce novel biologics enabled by synthetic chemistries,” shared Juan Alvarez, Vice President of Discovery Biologics at Merck Research Laboratories.
  • Backed by Khosla Ventures, Pearl Bio was launched by Scientific Co-Founders Drs.
  • (Pearl Bio) bringing together an exclusive platform technology to advance multi-functionalized biologics and biomaterials by encoding synthetic chemistries.

VEGAMOUR EXPANDS INTO CANADA EXCLUSIVELY WITH SEPHORA

Retrieved on: 
Lundi, janvier 8, 2024

The brand's range of clean, vegan, high-performance hair care products will be available at all 114  Sephora locations across Canada and on Sephora.ca.

Key Points: 
  • The brand's range of clean, vegan, high-performance hair care products will be available at all 114  Sephora locations across Canada and on Sephora.ca.
  • Vegamour is currently sold in Sephora across the U.S. with a presence in 535 store locations and online.
  • We have dedicated Sephora consumers within the U.S. who look to Vegamour to help them achieve their hair goals.
  • VEGAMOUR will launch at Sephora Canada stores and on Sephora.ca with the following assortment: GRO Hair Serum for Thinning Hair, GRO Hair Serum Trio for Thinning Hair, GRO Revitalizing Shampoo, GRO Revitalizing Conditioner, GRO Dry Shampoo, GRO Scalp Detoxifying Serum, GRO Revitalizing Scalp Massager and HYDR-8 Leave-In-Conditioner.

Nanolux Expands European Footprint with New Office in Spain

Retrieved on: 
Mardi, octobre 10, 2023

BARCELONA, Spain, Oct. 10, 2023 /PRNewswire/ -- Nanolux, a leading global horticultural lighting brand, has announced a partnership with Spain's IMHERE Distribution S.L. to launch the Nanolux European Sales and Customer Service Center. This initiative is designed to offer European customers quicker, more reliable, and cost-effective product delivery and technical support.

Key Points: 
  • BARCELONA, Spain, Oct. 10, 2023 /PRNewswire/ -- Nanolux, a leading global horticultural lighting brand, has announced a partnership with Spain's IMHERE Distribution S.L.
  • to launch the Nanolux European Sales and Customer Service Center.
  • This initiative is designed to offer European customers quicker, more reliable, and cost-effective product delivery and technical support.
  • Nanolux stands out as one of the few horticultural lighting brands with its own research and development as well as manufacturing teams.

GRO Biosciences Presents Preclinical Data on Two ProGly™ Programs for Non-Standard Amino Acid Therapies

Retrieved on: 
Mercredi, septembre 27, 2023

The Company’s genomically recoded organism (GRO) platform enables precise placement of non-standard amino acids (NSAAs) within a protein to realize previously unattainable therapeutic capabilities.

Key Points: 
  • The Company’s genomically recoded organism (GRO) platform enables precise placement of non-standard amino acids (NSAAs) within a protein to realize previously unattainable therapeutic capabilities.
  • ProGly NSAAs contain glycans that can elicit a defined immune response to the underlying protein.
  • Each ProGly NSAA carries a glycan-based tolerance signal that reeducates the immune system to recognize the underlying protein as “self” rather than “foreign”.
  • The Company presented data showing that ProGly produced a profound improvement in experimental autoimmune myasthenia gravis, a highly translatable animal model of MG.

Tacton Announces Strategic Investment from Rubicon Technology Partners

Retrieved on: 
Jeudi, juillet 13, 2023

CHICAGO and STOCKHOLM, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Tacton , the leading Configure, Price, Quote (CPQ) SaaS partner to manufacturers for simplifying sales in complex configuration, today announced it has secured a strategic investment from Rubicon Technology Partners  (“Rubicon”), a leading private equity firm based in Boulder, Colorado, that is focused exclusively on investing in and growing enterprise software companies.

Key Points: 
  • CHICAGO and STOCKHOLM, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Tacton , the leading Configure, Price, Quote (CPQ) SaaS partner to manufacturers for simplifying sales in complex configuration, today announced it has secured a strategic investment from Rubicon Technology Partners  (“Rubicon”), a leading private equity firm based in Boulder, Colorado, that is focused exclusively on investing in and growing enterprise software companies.
  • Additionally, Tacton’s investment partner since 2017, GRO Capital (“GRO”), will be a co-investor and join Rubicon in supporting the next phase of Tacton’s scaling journey.
  • Now, with the investment from and partnership with Rubicon, we have the opportunity to bring our innovative products to a broader base of global customers than ever before.
  • We are therefore grateful that GRO Fund III will continue the journey with Tacton together with Rubicon Technology Partners, who shares our vision for the company and undoubtedly will be able to accelerate Tacton’s path towards this vision.”
    For more information on Tacton and its market-leading configuration technology:
    Book a demo and see how Tacton can help your company increase efficiencies, sales volume and net profit

Curity Secures Investment to Scale Growth in API-Driven Identity Management

Retrieved on: 
Vendredi, mai 12, 2023

STOCKHOLM, May 12, 2023 /PRNewswire/ -- Cybersecurity firm, Curity, today announced a significant investment from GRO, a Danish private equity fund, to accelerate its international expansion. Curity is a leading provider of API-driven identity management, delivering solutions to a wide range of enterprises seeking to secure access to digital services.

Key Points: 
  • STOCKHOLM, May 12, 2023 /PRNewswire/ -- Cybersecurity firm, Curity, today announced a significant investment from GRO, a Danish private equity fund, to accelerate its international expansion.
  • Curity is a leading provider of API-driven identity management, delivering solutions to a wide range of enterprises seeking to secure access to digital services.
  • Curity sought a reputed and experienced investment partner to help facilitate product innovation and business growth.
  • Travis Spencer, co-founder and CEO of Curity, says of the investment, "This is an important milestone for Curity, and we are looking forward to working with GRO.

Itronics Updates Investors; Revenues Up 34 Percent

Retrieved on: 
Mardi, avril 25, 2023

Total Revenues for the 12 months ended December 31, 2022, were $2,089,780 compared to $1,559,109 in the same period in 2021, a 34 percent increase over the prior year.

Key Points: 
  • Total Revenues for the 12 months ended December 31, 2022, were $2,089,780 compared to $1,559,109 in the same period in 2021, a 34 percent increase over the prior year.
  • Entrance into the nursery markets will help expand GOLD'n GRO sales, while reducing the seasonal impact on revenues.
  • This presents an opportunity for Auric Gold & Minerals, Inc., a majority owned subsidiary of Itronics, to begin producing revenues, while directly benefiting Itronics with a cost-effective supply of raw materials.
  • Itronics recently restructured its Contract of Sale purchase agreement on the Wabuska property in Yerington, Nevada, which will become the Itronics Cleantech Materials Campus (ICMC).

GRO and Alfvén & Didrikson invest $29 million in Paligo to take SaaS-based Component Content Management to the next level

Retrieved on: 
Lundi, avril 17, 2023

Existing investor Alfvén & Didrikson ("A&D") will also follow on its investment into Paligo.

Key Points: 
  • Existing investor Alfvén & Didrikson ("A&D") will also follow on its investment into Paligo.
  • GRO becomes a minority investor in the company and through this investment, Paligo will accelerate its product vision, organizational expansion and international growth.
  • As a fast-growing company, Paligo supports enterprise and mid-market customers globally from its offices in Sweden, Ireland and the United States.
  • We couldn't be more excited to take the next steps in revolutionizing documentation and content management together with Alfvén & Didrikson and our new partners GRO."